• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白Eε4在阿尔茨海默病中的影响:基于体素形态学研究的荟萃分析

Impact of Apolipoprotein E ε4 in Alzheimer's Disease: A Meta-Analysis of Voxel-Based Morphometry Studies.

作者信息

Bailey Madison, Ilchovska Zlatomira G, Hosseini Akram A, Jung JeYoung

机构信息

School of Medicine, University of Nottingham, Nottingham, UK.

School of Psychology, University of Nottingham, Nottingham, UK.

出版信息

J Clin Neurol. 2024 Sep;20(5):469-477. doi: 10.3988/jcn.2024.0176.

DOI:10.3988/jcn.2024.0176
PMID:39227329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11372214/
Abstract

BACKGROUND AND PURPOSE

Alzheimer's disease (AD) is the most-prevalent form of dementia and imposes substantial burdens at the personal and societal levels. The apolipoprotein E (APOE) ε4 allele is a genetic factor known to increase AD risk and exacerbate brain atrophy and its symptoms. We aimed to provide a comprehensive review of the impacts of APOE ε4 on brain atrophy in AD as well as in mild cognitive impairment (MCI) as a transitional stage of AD.

METHODS

We performed a coordinate-based meta-analysis of voxel-based morphometry studies to compare gray-matter atrophy patterns between carriers and noncarriers of APOE ε4. We obtained coordinate-based structural magnetic resonance imaging data from 1,135 individuals who met our inclusion criteria among 12 studies reported in PubMed and Google Scholar.

RESULTS

We found that atrophy of the hippocampus and parahippocampus was significantly greater in APOE ε4 carriers than in noncarriers, especially among those with AD and MCI, while there was no significant atrophy in these regions in healthy controls who were also carriers.

CONCLUSIONS

The present meta-analysis has highlighted the significant link between the APOE ε4 allele and hippocampal atrophy in both AD and MCI, which emphasizes the critical influence of the allele on neurodegeneration, especially in the hippocampus. These findings improve the understanding of AD pathology, potentially facilitating progress in early detection, targeted interventions, and personalized care strategies for individuals at risk of AD who carry the APOE ε4 allele.

摘要

背景与目的

阿尔茨海默病(AD)是最常见的痴呆形式,在个人和社会层面都带来了沉重负担。载脂蛋白E(APOE)ε4等位基因是一种已知会增加AD风险并加剧脑萎缩及其症状的遗传因素。我们旨在全面综述APOE ε4对AD以及作为AD过渡阶段的轻度认知障碍(MCI)中脑萎缩的影响。

方法

我们对基于体素的形态学研究进行了基于坐标的荟萃分析,以比较APOE ε4携带者和非携带者之间的灰质萎缩模式。我们从PubMed和谷歌学术报告的12项研究中符合纳入标准的1135名个体中获取了基于坐标的结构磁共振成像数据。

结果

我们发现,APOE ε4携带者的海马体和海马旁回萎缩明显大于非携带者,尤其是在患有AD和MCI的人群中,而同样是携带者的健康对照者在这些区域没有明显萎缩。

结论

本荟萃分析突出了APOE ε4等位基因与AD和MCI中海马萎缩之间的显著联系,这强调了该等位基因对神经退行性变的关键影响,尤其是在海马体中。这些发现增进了对AD病理学的理解,可能有助于在对携带APOE ε4等位基因的AD风险个体进行早期检测、靶向干预和个性化护理策略方面取得进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d1/11372214/7743cfd98d34/jcn-20-469-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d1/11372214/85530fa2fc64/jcn-20-469-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d1/11372214/de36d74c7400/jcn-20-469-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d1/11372214/7743cfd98d34/jcn-20-469-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d1/11372214/85530fa2fc64/jcn-20-469-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d1/11372214/de36d74c7400/jcn-20-469-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d1/11372214/7743cfd98d34/jcn-20-469-g003.jpg

相似文献

1
Impact of Apolipoprotein E ε4 in Alzheimer's Disease: A Meta-Analysis of Voxel-Based Morphometry Studies.载脂蛋白Eε4在阿尔茨海默病中的影响:基于体素形态学研究的荟萃分析
J Clin Neurol. 2024 Sep;20(5):469-477. doi: 10.3988/jcn.2024.0176.
2
The impact of APOE ε4 in Alzheimer's disease: a meta-analysis of voxel-based morphometry studies.载脂蛋白Eε4在阿尔茨海默病中的影响:基于体素形态学研究的荟萃分析
medRxiv. 2024 May 10:2024.05.10.24307165. doi: 10.1101/2024.05.10.24307165.
3
ε4 allele status modulates the spatial patterns of progressive atrophy in the temporal lobes after mild traumatic brain injury.ε4等位基因状态可调节轻度创伤性脑损伤后颞叶渐进性萎缩的空间模式。
Alzheimers Dement (Amst). 2024 Feb 16;16(1):e12550. doi: 10.1002/dad2.12550. eCollection 2024 Jan-Mar.
4
AD Resemblance Atrophy Index of Brain Magnetic Resonance Imaging in Predicting the Progression of Mild Cognitive Impairment Carrying Apolipoprotein E-ε4 Allele.脑磁共振成像的AD相似性萎缩指数在预测携带载脂蛋白E-ε4等位基因的轻度认知障碍进展中的作用
Front Aging Neurosci. 2022 Apr 28;14:859492. doi: 10.3389/fnagi.2022.859492. eCollection 2022.
5
The ε4 variant and hippocampal atrophy in Alzheimer's disease and Lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance.阿尔茨海默病和路易体痴呆症中 ε4 变体与海马萎缩:磁共振成像研究的系统评价及治疗相关性。
Expert Rev Neurother. 2021 Aug;21(8):851-870. doi: 10.1080/14737175.2021.1956904. Epub 2021 Aug 13.
6
Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia.载脂蛋白Eε4与阿尔茨海默病和额颞叶痴呆中脑萎缩的疾病特异性影响相关。
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):2018-22. doi: 10.1073/pnas.0812697106. Epub 2009 Jan 22.
7
Brain Homotopic Connectivity in Mild Cognitive Impairment APOE-ε4 Carriers.轻度认知障碍 APOE-ε4 携带者的脑同位连接性
Neuroscience. 2020 Jun 1;436:74-81. doi: 10.1016/j.neuroscience.2020.04.011. Epub 2020 Apr 15.
8
Selective brain gray matter atrophy associated with APOE ε4 and MAPT H1 in subjects with mild cognitive impairment.与 APOE ε4 和 MAPT H1 相关的轻度认知障碍患者的选择性脑灰质萎缩。
J Alzheimers Dis. 2013;33(4):1009-19. doi: 10.3233/JAD-2012-121174.
9
Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.从阿尔茨海默病临床前期到痴呆阶段的认知、脑萎缩和脑脊液生物标志物变化以及载脂蛋白E的影响
J Alzheimers Dis. 2015;45(1):253-68. doi: 10.3233/JAD-142451.
10
APOE ε4/ε4 homozygotes with early Alzheimer's disease show accelerated hippocampal atrophy and cortical thinning that correlates with cognitive decline.患有早期阿尔茨海默病的 APOE ε4/ε4 纯合子表现出加速的海马萎缩和皮质变薄,这与认知衰退相关。
Alzheimers Dement (N Y). 2020 Dec 4;6(1):e12117. doi: 10.1002/trc2.12117. eCollection 2020.

引用本文的文献

1
Age-related amyloid beta dynamics modeled with the generalized additive model for location, scale, and shape (GAMLSS) across diverse populations: Cross-sectional trajectories and longitudinal validation.使用位置、尺度和形状广义相加模型(GAMLSS)对不同人群中与年龄相关的淀粉样β动力学进行建模:横断面轨迹和纵向验证。
Alzheimers Dement. 2025 Sep;21(9):e70675. doi: 10.1002/alz.70675.
2
Current Clinical Applications of Structural MRI in Neurological Disorders.结构磁共振成像在神经系统疾病中的当前临床应用
J Clin Neurol. 2025 Jul;21(4):277-293. doi: 10.3988/jcn.2025.0185.
3
Imaging markers of neuroinflammation in aging and Alzheimer's disease and related dementia: A comprehensive review.

本文引用的文献

1
Burden of Illness in People with Alzheimer's Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality.阿尔茨海默病患者的疾病负担:流行病学、合并症和死亡率的系统评价。
J Prev Alzheimers Dis. 2024;11(1):97-107. doi: 10.14283/jpad.2023.61.
2
The APOE4 effect: structural brain differences in Alzheimer's disease according to the age at symptom onset.载脂蛋白 E4 效应:根据症状发病年龄的不同,阿尔茨海默病患者大脑结构存在差异。
Eur J Neurol. 2023 Mar;30(3):597-605. doi: 10.1111/ene.15657. Epub 2022 Dec 20.
3
Time to retire the serial Papez circuit: Implications for space, memory, and attention.
衰老、阿尔茨海默病及相关痴呆症中神经炎症的影像学标志物:综述
Neurosci Biobehav Rev. 2025 Jun 25;176:106270. doi: 10.1016/j.neubiorev.2025.106270.
4
Monoclonal Antibodies-A New Horizon in Alzheimer's Treatment.单克隆抗体——阿尔茨海默病治疗的新视野。
J Clin Neurol. 2025 Jan;21(1):1-2. doi: 10.3988/jcn.2024.0527.
5
Navigating the Alzheimer's Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics.探索阿尔茨海默病生物标志物领域:基于体液的诊断方法全面分析。
Cells. 2024 Nov 18;13(22):1901. doi: 10.3390/cells13221901.
6
Tooth Loss in Periodontitis Patients-A Risk Factor for Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.牙周炎患者牙齿缺失——轻度认知障碍的一个风险因素:一项系统评价与Meta分析
J Pers Med. 2024 Sep 9;14(9):953. doi: 10.3390/jpm14090953.
7
In 2024, the still remains a working hypothesis, no less but certainly no more.在2024年,这仍然只是一个工作假设,仅此而已,绝非定论。
Front Aging Neurosci. 2024 Sep 4;16:1459224. doi: 10.3389/fnagi.2024.1459224. eCollection 2024.
8
Impact of Apolipoprotein E ε4 in Alzheimer's Disease: Insights From a Meta-Analysis.载脂蛋白Eε4在阿尔茨海默病中的作用:一项荟萃分析的见解
J Clin Neurol. 2024 Sep;20(5):467-468. doi: 10.3988/jcn.2024.0353.
是时候淘汰串行 Papez 回路了:对空间、记忆和注意力的影响。
Neurosci Biobehav Rev. 2022 Sep;140:104813. doi: 10.1016/j.neubiorev.2022.104813. Epub 2022 Aug 5.
4
Correlation Between Brain Structure Atrophy and Plasma Amyloid-β and Phosphorylated Tau in Patients With Alzheimer's Disease and Amnestic Mild Cognitive Impairment Explored by Surface-Based Morphometry.基于表面形态测量法探索阿尔茨海默病和遗忘型轻度认知障碍患者脑结构萎缩与血浆淀粉样β蛋白及磷酸化tau蛋白之间的相关性
Front Aging Neurosci. 2022 Apr 25;14:816043. doi: 10.3389/fnagi.2022.816043. eCollection 2022.
5
2022 Alzheimer's disease facts and figures.2022 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2022 Apr;18(4):700-789. doi: 10.1002/alz.12638. Epub 2022 Mar 14.
6
Hippocampus and its involvement in Alzheimer's disease: a review.海马体及其在阿尔茨海默病中的作用:综述
3 Biotech. 2022 Feb;12(2):55. doi: 10.1007/s13205-022-03123-4. Epub 2022 Feb 1.
7
Don't forget about tau: the effects of ApoE4 genotype on Alzheimer's disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment-data from the Dementia Competence Network.不要忽视 tau:载脂蛋白 E4 基因型对轻度认知障碍患者阿尔茨海默病脑脊液生物标志物的影响——来自痴呆能力网络的数据。
J Neural Transm (Vienna). 2022 Jun;129(5-6):477-486. doi: 10.1007/s00702-022-02461-0. Epub 2022 Jan 21.
8
The Influence of MTHFR Polymorphism on Gray Matter Volume in Patients With Amnestic Mild Cognitive Impairment.亚甲基四氢叶酸还原酶(MTHFR)基因多态性对遗忘型轻度认知障碍患者脑灰质体积的影响
Front Neurosci. 2021 Nov 30;15:778123. doi: 10.3389/fnins.2021.778123. eCollection 2021.
9
Going round in circles-The Papez circuit in Alzheimer's disease.在阿尔茨海默病中兜兜转转——帕佩兹环路。
Eur J Neurosci. 2021 Nov;54(10):7668-7687. doi: 10.1111/ejn.15494. Epub 2021 Nov 2.
10
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.